Parmax Pharma Ltd — Insider Trading, 01-01-1970: Insider Trading / SAST

Parmax Pharma's promoter group has significantly increased its holding through a preferential allotment. The group acquired 22,80,444 equity shares and 17,16,574 warrants. This transaction boosted the promoter group's stake from 58.01% to 68.34% of the total diluted share capital. Following the allotment, the company's equity share capital expanded from ₹3.74 Cr to ₹6.88 Cr, with total diluted capital reaching ₹9.02 Cr. This move underscores strong promoter confidence and fresh capital infusion into the company.